A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

• Autori principali: Cristina Villanueva-Bueno (Autore), Roberto Collado-Borrell (Autore), Vicente Escudero-Vilaplana (Autore), José Luis Revuelta-Herrero (Autore), María Belén Marzal-Alfaro (Autore), Eva González-Haba (Autore), José Ángel Arranz-Arija (Autore), Santiago Osorio (Autore), Ana Herranz-Alonso (Autore), María Sanjurjo-Saez (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

ObjectiveThis study aims to analyze the impact of the eOncosalud app on the management and follow-up of adverse effects (AE) in patients receiving oral antineoplastic agents.Material and methodsWe performed an observational, prospective study of cancer outpatients treated with oral antineoplastic ag...